Cadrenal Therapeutics, Inc. financial statement history

What this record covers

This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.

Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.

Total assets

Current assets

Cash and cash equivalents

Property, plant and equipment

Total liabilities

Current liabilities

Stockholders equity

Cost of revenue

Research and development

Operating income

Net income

Diluted earnings per share

Operating cash flow

Capital expenditure

Source and method

SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.

The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.

Source filer CIK

1937993

Ticker in native snapshot

CVKD

Reported numeric facts

53

Units present

USD · USD/shares

• SEC companyfacts source
• SEC XBRL data documentation
• SEC website dissemination policy